Back to Search
KATHRYN THRAILKILL, MD
MD
Pediatric Endocrinology Physician
NPI: 1255421814Individual
Specialties, Licenses & Credentials
Pediatric Endocrinology PhysicianPrimary
Pediatrics — Pediatric Endocrinology
Code: 2080P0205X
E-3437(AR)32544(KY)
Research & Publications (20)
The effects of co-therapy with recombinant human insulin-like growth factor I and insulin on serum leptin levels in adolescents with type 1 diabetes mellitus.
PMID 15016207·Pediatr Diabetes·2001
8-other
Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility.
PMID 11467325·Diabetes Technol Ther·2000
6-review
Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF.
PMID 19580462·J Bone Miner Res·2010
7-preclinical
Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin.
PMID 19366958·Diabetes Care·2009
8-other
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.
PMID 18972226·Endocrine·2009
6-review
Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus.
PMID 18162513·Endocrinology·2008
7-preclinical
Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.
PMID 17595258·J Clin Endocrinol Metab·2007
4-observational
Severe deficiencies of IGF-I, IGF-II, IGFBP-3, ALS and paradoxically high-normal bone mass in a child with insulin-resistance syndrome (Rabson-Mendenhall type).
PMID 17560154·Growth Horm IGF Res·2007
5-case
A novel rat model for the study of deficits in bone formation in type-2 diabetes.
PMID 17453392·Acta Orthop·2007
7-preclinical
Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model.
PMID 16939394·J Bone Miner Res·2006
7-preclinical
Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens.
PMID 16599849·Clin Chem Lab Med·2006
8-other
Investigational agents for the treatment of growth hormone-insensitivity syndrome.
PMID 16548790·Expert Opin Investig Drugs·2006
6-review
Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.
PMID 16309379·Clin Chem Lab Med·2005
4-observational
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.
PMID 16215165·Am J Physiol Endocrinol Metab·2005
6-review
SomatoKine: is there a use in treating growth disorders?
PMID 15898344·Curr Opin Investig Drugs·2005
6-review
Regulation of insulin-like growth factor (IGF)-I action by matrix metalloproteinase-3 involves selective disruption of IGF-I/IGF-binding protein-3 complexes.
PMID 14605000·Endocrinology·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 740 S LIMESTONE ST
LEXINGTON, KY 40536 - Phone
- (859) 323-5404
Quick Facts
- NPI
- 1255421814
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile